Growth factors and the development of diabetic nephropathy

被引:38
作者
Gunter Wolf
机构
[1] University of Hamburg, Department of Medicine, Div. of Nephrol. Rheumatol./Osteol., Hamburg D-20246
关键词
Vascular Endothelial Growth Factor; Diabetic Nephropathy; Mesangial Cell; Connective Tissue Growth Factor; Proximal Tubular Cell;
D O I
10.1007/s11892-003-0012-2
中图分类号
学科分类号
摘要
Growth factors play an important role in the development of functional and structural changes associated with diabetic nephropathy. Although it has been known for years that these factors are important for early renal hypertrophy and subsequent development of glomerulosclerosis and tubulointerstitial fibrosis, the exact molecular mechanism of many of these factors has only recently been more elucidated. Furthermore, growth factors also link the metabolic theory of diabetic complications with renal hemodynamic changes in diabetic nephropathy because some growth factors could directly influence glomerular hemodynamics and tubular transport in diabetic nephropathy. The high glucose environment with stimulated cellular uptake of glucose and accelerated nonenzymatic reactions resulting in Amadori-modified proteins and the later-developing advanced glycation end products are the main stimulators for intrarenal induction of growth factors. Intracellular generation of reactive species is an important signal intermediate in these stimulated expressions of growth factors. Taking into consideration the pivotal role of growth factors in the development of diabetic nephropathy, a therapeutic strategy to antagonize growth factor effects appears to be straightforward. However, the pleiotropic function of many of these factors and their physiologic role in normal renal homeostasis may make this approach difficult. Copyright © 2003 by Current Science Inc.
引用
收藏
页码:485 / 490
页数:5
相关论文
共 50 条
[1]  
Wolf G., Ziyadeh F.N., Molecular mechanisms of diabetic renal hypertrophy, Kidney Int., 56, pp. 393-405, (1999)
[2]  
Wolf G., Chen S., Han D.C., Ziyadeh F.N., Leptin and renal disease, Am. J. Kidney Dis., 39, pp. 1-11, (2002)
[3]  
McGowan T.A., Madesh M., Zhu Y., Et al., TGF-beta-induced Ca2+ influx involves the type III IP3 receptor and regulates actin cytoskeleton, Am. J. Physiol. Renal Physiol., 282, (2002)
[4]  
Brownlee M., Biochemistry and molecular cell biology of diabetic complications, Nature, 414, pp. 813-820, (2001)
[5]  
Murphy M., Godson C., Cannon S., Et al., Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells, J. Biol. Chem., 274, pp. 5830-5834, (1999)
[6]  
Flyvbjerg A., Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease, Diabetologia, 43, pp. 1205-1223, (2000)
[7]  
Gooch J.L., Tang Y., Ricono J.M., Abboud H.E., Insulin-like growth factor-I induces renal cell hypertrophy via a calcineurin-dependent mechanism, J. Biol. Chem., 276, pp. 42492-42500, (2001)
[8]  
Lupia E., Elliot S.J., Lenz O., Et al., IGF-1 decreases collagen degradation in diabetic NOD mesangial cells. Implications for diabetic nephropathy, Diabetes, 48, pp. 1638-1644, (1999)
[9]  
Gruden G., Araf S., Zonca S., Et al., IGF-I induces vascular endothelial growth factor in human mesangial cells via a Src-dependent mechanism, Kidney Int., 63, pp. 1249-1255, (2003)
[10]  
Cummings E.A., Sochett E.B., Dekker M.G., Et al., Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes, Diabetes, 47, pp. 1341-1346, (1998)